Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple drug stop nausea during emergency C-Sections?

NCT ID NCT07740577

Not yet recruiting Disease control Sponsor: Sanliurfa Education and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests whether giving a preventive anti-nausea drug before an emergency cesarean section under spinal anesthesia can reduce nausea, retching, or vomiting during surgery. It focuses on women who have not fasted, which may increase the risk of these symptoms. The study compares two common medications, ondansetron and metoclopramide, to see which works better. The goal is to improve comfort and safety for mothers during this procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ondansetron and metoclopramide
What this could lead to
If effective, this could help standardize antiemetic use during emergency cesareans, improving maternal comfort and reducing complications.
What could go wrong
The trial is relatively small and focuses on a specific population, so results may not apply broadly. Both drugs have known side effects, and the study is not designed to prove long-term benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIEMETIC THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Vomiting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTIEMETIC THERAPY CESEREAN SECTION INTRAOPERATIVE NAUSEA-RETCHING-VOMITING EPISODES METOCLOPRAMIDE ONDANSETRON SPINAL ANESHTESIA

Contacts and locations

Locations

  • Sanliurfa Education and Research Hospital

    Sanliurfa, Eyyübiye, 63040, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.